Quantify was represented at the IPECAD conference (International Pharmaco-Economic Conference on Alzheimer’s Disease), which was held 15-16 February 2018 in Paris. Anders Gustavsson, founding partner at Quantify and one of the co-organizers of the conference, held a presentation about modelling approaches in Alzheimer’s disease. Quantify’s Josefine Röhss attended the conference as a medical writer and will write a manuscript which summarizes the presentations, discussions and conclusions made at the conference. The main areas of discussion included the challenges of early detection of Alzheimer’s disease and collaboration between research groups and countries in order to share data and research. More information about IPECAD can be found at IPECAD.org.